Evoke Pharma, Inc. (EVOK)
NASDAQ: EVOK · Real-Time Price · USD
5.07
-0.42 (-7.65%)
Dec 20, 2024, 4:00 PM EST - Market closed

Evoke Pharma Revenue

Evoke Pharma had revenue of $2.65M in the quarter ending September 30, 2024, with 69.83% growth. This brings the company's revenue in the last twelve months to $8.62M, up 100.35% year-over-year. In the year 2023, Evoke Pharma had annual revenue of $5.18M with 106.51% growth.

Revenue (ttm)
$8.62M
Revenue Growth
+100.35%
P/S Ratio
0.87
Revenue / Employee
$2,154,259
Employees
4
Market Cap
10.48M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20235.18M2.67M106.51%
Dec 31, 20222.51M890.57K55.04%
Dec 31, 20211.62M1.60M6,929.00%
Dec 31, 202023.02K--
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Zhongchao 17.41M
Sol-Gel Technologies 11.71M
Immuron 3.27M
Lyra Therapeutics 1.47M
AIM ImmunoTech 190.00K
Revenue Rankings